{"transactions":[{"id":744935,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":40123,"kind":"person","name":"Stillwell Richard Newcomb","position":1,"cik":"0001966861","reported_name":"Stillwell Richard Newcomb","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2026-06-09T21:30:04.000Z","date":"2026-06-08","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":11.65,"value":58250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $11.63 to $11.65 per share. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001493152-26-027985","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1966861/000149315226027985/ownership.xml","form_type":"4"}},{"id":779450,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":40123,"kind":"person","name":"Stillwell Richard Newcomb","position":1,"cik":"0001966861","reported_name":"Stillwell Richard Newcomb","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-14T21:48:35.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."}],"balance_after":22700,"derivative":{"exercise_price":13.28,"exercise_date":"2027-05-12","expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001999371-26-010754","document":"stillwell-form4_051426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1966861/000199937126010754/stillwell-form4_051426.xml","form_type":"4"}},{"id":1147701,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":40123,"kind":"person","name":"Stillwell Richard Newcomb","position":1,"cik":"0001966861","reported_name":"Stillwell Richard Newcomb","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-15T20:51:59.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."}],"balance_after":10000,"derivative":{"exercise_price":20.18,"exercise_date":"2026-05-13","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001999371-25-006245","document":"stillwell-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1966861/000199937125006245/stillwell-form4.xml","form_type":"4"}},{"id":1502251,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":40123,"kind":"person","name":"Stillwell Richard Newcomb","position":1,"cik":"0001966861","reported_name":"Stillwell Richard Newcomb","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-05-24T21:07:45.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":104621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":104621,"derivative":{"exercise_price":0.1745,"exercise_date":"2025-05-23","expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":104621},"source":{"system":"sec-edgar","filing":"0001999371-24-006623","document":"stillwell-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1966861/000199937124006623/stillwell-form4.xml","form_type":"4"}},{"id":1898338,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":40123,"kind":"person","name":"Stillwell Richard Newcomb","position":1,"cik":"0001966861","reported_name":"Stillwell Richard Newcomb","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-05-10T21:09:49.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."}],"balance_after":60000,"derivative":{"exercise_price":0.509,"exercise_date":"2024-05-08","expiration_date":"2033-05-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001839882-23-012501","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1966861/000183988223012501/ownership.xml","form_type":"4"}},{"id":1950312,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":40123,"kind":"person","name":"Stillwell Richard Newcomb","position":1,"cik":"0001966861","reported_name":"Stillwell Richard Newcomb","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-03-16T23:43:34.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":83000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests on the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":83000,"derivative":{"exercise_price":0.562,"expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":83000},"source":{"system":"sec-edgar","filing":"0001839882-23-006928","document":"stillwell-form4_031523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1966861/000183988223006928/stillwell-form4_031523.xml","form_type":"4"}}]}